• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Manufacturing
    • Markets
    • Top 10
    • Buyers' Guide
    • Events
    • Microsites
    • More
  • Magazine
  • News
  • Exclusives
  • Manufacturing
  • Markets
  • Top 10
  • Buyers' Guide
  • Events
  • Microsites
  • Current & Past Issues
    Features
    Departments
    Columns
    Editorial
    Digital Edition
    Subscribe Now
    Advertise Now
    Editorial Guidelines
    eNewsletter Archive
    eBook
    Top Features
    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Next Steps for Recovery and Rehab

    Scratching the Surface: A Roundtable on Coatings and Treatments

    Influencers on the Orthopedic Implant Manufacturing Market
    Breaking News
    Certifications
    Clinical Trials
    Device Approvals & Patents
    Financial & Deals
    International
    Market Data & Trends
    OEM News
    Orthopedic Innovators
    People
    Product & Service Releases
    Products
    Quality, Recalls & Risk
    Regulatory & Legal
    Supplier & Contract Mfg.
    Live From Shows
    Top News & Features
    Integra LifeSciences Founder Dr. Richard Caruso Passes Away

    FDA Clears CTL Amedica's Navigation Instrument System

    FundamentalVR Raises $20 Million in Series B Funding

    Bioventus Achieves Strong Growth in Q2 2022

    Bone Void Fillers Market Growing at 6%
    3-D Printing/Additive Mfg.
    Assembly & Automation
    Biocompatibility & Testing
    Clean Room
    Coatings/Surface Modification
    Contract Manufacturing
    Design
    Extrusion
    Finishing
    Forging & Casting
    Instruments, Cases & Trays
    International/Offshoring
    Laser Processing
    Materials
    Machining & Tooling
    Molding
    Packaging & Sterilization
    Prototyping
    Research & Developement
    Software & Quality
    Staffing, Training & Prof. Dev.
    Supply Chain

    The ODT 2022 Top 10 Orthopedic Device Companies

    Additive Manufacturing at the Point of Care

    Six Orthopedic Firms En Route to Significant Market Disruption

    The Genetic Risk for Joint Replacement Failure

    The Case for Using Historical Control in Clinical Trial Design
    Biologics
    Bracing/Prosthetics
    Extremities
    Imaging
    Instruments
    Large Joint
    MIS/Robotics
    Spine/Neurology
    Trauma/Sports
    Top Markets
    Orthopedic Device Evolution is Driven by Precision Technology

    mdHACM Allografts Demonstrate Potential in Treating Knee Osteoarthritis

    Radically Improving Medicine & Surgery with Light Field Technology

    A Call to Action in Orthopedics: We Need to Personalize Every Single Hip and Knee Surgery

    Giving Knee Replacement Surgery a Much-Needed Update
    Companies
    Categories
    Company Capabilities
    White Papers
    Add New Company
    International Buyers Guide Companies
    Tiodize

    Life Science Outsourcing Inc.

    Braxton Manufacturing

    Modern Plastics

    AV&R
    Industry Events
    Webinars
    • Magazine
      • Current & Past Issues
      • Features
      • Editorial
      • Departments
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • eBook
    • Breaking News
    • Buyers' Guide
      • Companies
      • Categories
      • Company Capabilities
      • White Papers
      • Add Your Company
    • Manufacturing
      • 3-D Printing/Additive Mfg.
      • Assembly & Automation
      • Biocompatibility & Testing
      • Clean Room
      • Coatings/Surface Modification
      • Contract Manufacturing
      • Design
      • Extrusion
      • Finishing
      • Forging & Casting
      • Instruments, Cases & Trays
      • International/Offshoring
      • Laser Processing
      • Materials
      • Machining & Tooling
      • Molding
      • Packaging & Sterilization
      • Prototyping
      • Research & Developement
      • Software & Quality
      • Staffing, Training & Prof. Dev.
      • Supply Chain
    • Markets
      • Biologics
      • Bracing/Prosthetics
      • Extremities
      • Imaging
      • Instruments
      • Large Joint
      • MIS/Robotics
      • Spine/Neurology
      • Trauma/Sports
    • Top 10
    • Online Exclusives
    • Slideshows
    • Videos
    • Webinars
    • Events
      • Industry Events
    • Live from Show Event
    • About Us
      • About Us
      • Contact Us
      • Privacy Policy
      • Terms of Use
      • Advertise With Us
    Features

    Pandemic Creates Conditions for Buying Bonanza—2021 Year in Review

    2021 offered a strong rebound in M&A activity in medtech, fueled by a record high of nearly $500 billion in financial firepower.

    Pandemic Creates Conditions for Buying Bonanza—2021 Year in Review
    Michael Barbella, Managing Editor11.17.21
    The pundits were right.

    They watched medtech profits tank last year during COVID-19’s initial assault, then gradually rebound in the second half. They knew of the changes ahead for U.S. tax laws, and the likely implications for publicly-traded companies. They observed the steady buildup of liquidity amongst major players throughout 2020. And they sensed the pent-up demand that had been bubbling up like magma within the industry during the pandemic.

    The pundits could draw only one conclusion from their observances: a strong rebound in M&A activity this year, fueled by a record high of nearly $500 billion in financial firepower.

    “There’s a lot of liquidity in the market,” John Babbitt, EY’s MedTech leader for the Americas, said in early January. “There are only so many levers that CEOs and CFOs can pull to enhance growth coming out of COVID. We do think, from what we’re hearing, that M&A is going to be one of the levers that they’re going to be relatively aggressive on.”

    Indeed, medtech companies aggressively yanked that lever in 2021, generating a bumper crop of deals that are likely to change the face of the industry. The number of transactions surpassed 2020’s total by mid-year, with buyouts occurring in virtually every industry sector.

    Orthopedic firms were considerably more passive with that lever, however. Deal size and scale were relatively small compared to the overall medtech industry: values ranged from $50 million to $518 million, with most transaction terms remaining undisclosed. Interestingly, small and medium-sized companies dominated deal-making this year, compensating for the lack of participation from the typically spendthrift multinationals.

    Nevertheless, the industry’s largest implant manufacturers were not completely MIA from 2021 M&A. Bioventus, DePuy Synthes Inc., DJO, NuVasive Inc., and Stryker Corp. freed up some cash for investment purposes to expand their existing product lines or delve into new markets.

    DePuy Synthes, for example, through its Synthes GMBH subsidiary, augmented its robotics capabilities through the $79.5 million purchase of Trendlines portfolio firm OrthoSpin Ltd. in early November. OrthoSpin’s robotic system for exterior fixation therapies received U.S. Food and Drug Administration clearance in January; the automated, digitally-enabled AutoStrut G2 System is used in setting complex fractures, correcting limb deformities, and bone lengthening procedures. The product converts the traditional manual external fixation system via an automatic process that complies with a treatment plan created by external fixation software. 

    Similarly, NuVasive expanded its cervical spine technology portfolio with its $150 million buyout of Simplify Medical. “The acquisition...advances our long-term growth strategy by both expanding, and further distinguishing, our portfolio with industry-leading innovation,” CEO J. Christopher Barry said upon disclosing the deal.

    DJO achieved the same goals with its bids for MedShape Inc. and Trilliant Surgical, and its strategic investment in Insight Medical Systems. The latter venture gives DJO access to the fast-growing augmented reality market (expected to top $16.2 billion by 2027), while the others provide the company entry into the foot/ankle sector. DJO’s reconstruction business also received a boost from Colfax Corporation’s $285 million purchase of Mathys AG Bettlach.

    Stryker, meanwhile, bolstered its sensor technology aptitude with its acquisition of OrthoSensor, whose VERASENSE intraoperative sensor has been used with  the company’s Triathlon knee since 2011. In addition, the firm sharpened its blood loss monitoring skills by purchasing Gauss Surgical, maker of an artificial intelligence-powered platform for monitoring a patient’s blood loss during surgery as well as following Cesarean sections and childbirth. Gauss Surgical’s Triton system uses a computer vision app and iPhone to visually measure blood loss by capturing images of sponges, towels, and fluid canisters held up to the camera, along with automatically calculating the blood volume of weighted items.

    The Gauss acquisition quickly followed Stryker’s mid-August launch of its SurgiCount+ sponge-counting workstation, designed to track blood-stopping equipment used during OR procedures.

    “In today’s strong market, we continue to see a significant amount of activity with both our Industry and Private Equity clients,” explained Craig Ackerman, a principal at the Alexander Group and leader of the firm’s Medical Device practice. “Many of the deals are tuck-in while others represent significant strategic investments. Medtech companies weathered the pandemic much better than expected and have money to invest in acquisitions. While some companies delayed their plans in 2020, most of today’s deals are being driven by strategic priorities.”

    That drive was particularly strong for Bioventus Inc., the year’s top shopper. The Durham, N.C.-based firm completed four deals in 2021, welcoming Bioness Inc., CartiHeal Ltd., and Misonix Inc. into the fold, and investing in Trice Medical Inc. The $110 million Bioness deal adds peripheral nerve stimulation technology and an advanced rehabilitation business to Bioventus’ product lineup, while CartiHeal expands the company’s ability to treat cartilage and osteochondral defects in patients with severe osteoarthritis (via CartiHeal’s biocompatible, coral-based, off-the-shelf implant, Agili-C).

    Misonix’s wound care portfolio (secured in the year’s largest deal, $518 million) will integrate with Bioventus’ foot/ankle offerings, and its surgical devices will augment its purchaser’s orthopedic tool lineup. Misonix’s Nexus ultrasonic system combines the BoneScalpel, SonicOne, and SonaStar tools in one platform for precision bone cutting, wound cleaning, and tissue removal, respectively.

    The Trice Medical investment enhances Bioventus’ minimally invasive technologies for sports medicine and orthopedic surgeries. The deal gave Bioventus exclusive sales and distribution rights to Trice Medical’s products outside the United States, as well as the opportunity to integrate Trice Medical’s technologies into its own peripheral nerve stimulation offerings, including StimRouter and TalisMann.

    Tuck-in deals were popular this year among the megacorps’ smaller rivals too. Neo Medical expanded its U.S. and German footprints by merging with TriOs Medical; Mediliant continued its contract manufacturing quest by purchasing CTE Solutions; Paragon 28 added a patient-specific total talus replacement solution to its portfolio by acquiring Additive Orthopaedics; and SeaSpine Holdings Corporation augmented its implants, instruments, and orthobiologics portfolio with its $110 million deal for 7D Surgical Inc.

    “The forced ‘pause’ and extended disruption [of COVID-19] caused many leaders to rethink their commercial models and organizational capabilities,” Ackerman noted. “As a result, healthcare leaders looked to acquire new capabilities needed to succeed in the updated ecosystem (e.g., technology, digital, etc.). Similar to the home renovation boom caused by millions of Americans working from home, companies took a similar inventory of their organizations and decided that they could use a bit of ‘fixing up’ or a nice new addition.”

    Some of those fixes, however, required a partial product portfolio realignment: Ventrun LLC sold its Universal Splint product line to Safeguard Medical, while Sunstar unloaded its Degradable Solutions division on Collagen Matrix Inc., and Stryker handed off its T/Pump dossier to C2Dx Inc.

    Anatomage, Colfax, and Zimmer Biomet Holdings Inc., on the other hand, beget new offspring. Anatomage separated its medical and dental businesses, creating a wholly-owned subsidiary for the latter called Osteoid; Colfax turned its industrial and medical device businesses into two separate companies; and Zimmer Biomet spun off its Spine and Dental divisions.

    Creating an independent spine and dental business will allow both Zimmer Biomet and the new entity (NewCo) to better focus on efficiency and leadership in their respective spaces, executives said. The spinoff is expected to be completed in mid-2022.

    “The year in M&A has been incredibly frothy,” said Ben Dunn, managing director at Boston-based investment banking firm Covington Associates. “Deal activity and valuations are at highs compared to the recent past. There was a lot of pent-up demand on the buy side and sell side. You had buyers who needed to do deals or put money to work and strategics who had new things they wanted to address because of COVID, and one of the ways to do that was through acquisition. It was a perfect storm leading to robust M&A activity.”

    Just the kind of storm the industry needed.

    Let it rain. 

    Read more: bit.ly/odt21yir04  



    Be sure to review the other portions of the 2021 Year in Review feature:

    MDR Finally Arrives, but Challenges Follow
     
    Supply Chain Struggles Plague Orthopedic Manufacturers
     
    CMS Creates Reimbursement Quagmire for ASCs
    Loading, Please Wait..

    Trending
    • MdHACM Allografts Demonstrate Potential In Treating Knee Osteoarthritis
    • Additive Manufacturing At The Point Of Care
    • Bioventus Launches DUROLANE In The U.S.
    • FundamentalVR Raises $20 Million In Series B Funding
    • Future Stars Of The Spine Industry: The Companies To Watch, 2021
    Breaking News
    • Integra LifeSciences Founder Dr. Richard Caruso Passes Away
    • FDA Clears CTL Amedica's Navigation Instrument System
    • FundamentalVR Raises $20 Million in Series B Funding
    • Bioventus Achieves Strong Growth in Q2 2022
    • Bone Void Fillers Market Growing at 6%
    View Breaking News >
    CURRENT ISSUE

    July/August 2022

    • Additive Manufacturing at the Point of Care
    • Six Orthopedic Firms En Route to Significant Market Disruption
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Vitamin K2 May Ameliorate Polycystic Ovary Syndrome
    Vitamin D May Prevent Changes to Liver Enzymes and Lipid Profile After Exhaustive Exercise
    Omega-3 Fatty Acids Linked to Reduced Episodes of Depression
    Coatings World

    Latest Breaking News From Coatings World

    The BEHR & KILZ Brands Partner with Leanne Ford to Revitalize Her Historic American Home
    IGM Resins Acquires Litian
    Ingevity to Acquire Pavement Marking Materials Business, Ozark Materials
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    TransMed7 Achieves First-in-Human for Heron Soft Tissue Biopsy Devices
    West Pharmaceutical Services Invests in Latch Medical
    Integra LifeSciences Founder Dr. Richard Caruso Passes Away
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Societal CDMO Inks Land Sell Deal
    RoosterBio and AGC Biologics to Accelerate Manufacturing of Cell and Exosome Therapies
    WuXi Advanced Therapies Enters Licensing Agreement with Janssen
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Johnson & Johnson to Discontinue Global Sales of Talc-Based Baby Powder
    Dr. Squatch To Launch a 2nd Star Wars Soap Collection
    Neopac Wins 2 European Tube Manufacturers Association Awards
    Happi

    Latest Breaking News From Happi

    Climate Change Drives Sustainability in Household & Personal Care
    Japonesque Acquires Foot Care Brand Barefoot Scientist
    Inolex Launches New Cannabis-Derived Ingredient for Sustainable Conditioning and Emulsification
    Ink World

    Latest Breaking News From Ink World

    BASF Breaks Ground on Riverfront Park in East Newark
    Roland DG Corporation to Relocate HQ to Miyakoda, Japan
    Gallus Launches Gallus One, Its First Fully Digital Inkjet Label Press
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    FINAT reports decrease in labelstock consumption during first half of 2022
    Color-Logic partners to feature metallics at autumn events
    New Era Converting Machinery heads to The Battery Show
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Tranzonic Acquired by Private Investment Firm
    Monadnock Earns EcoVadis Gold Rating
    Suominen Announces Price Surcharges
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Integra LifeSciences Founder Dr. Richard Caruso Passes Away
    FDA Clears CTL Amedica's Navigation Instrument System
    FundamentalVR Raises $20 Million in Series B Funding
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    onsemi Celebrates Expansion of Silicon Carbide Production Facility in New Hampshire
    Applied Materials CTO Dr. Om Nalamasu Receives IEEE Frederik Philips Award
    Weekly Recap: ALTANA, Universal Display and Emerson Top This Week’s Stories

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login